Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-10-27
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0920-9964
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-9
|
pubmed:dateRevised |
2010-9-2
|
pubmed:meshHeading |
pubmed-meshheading:7547649-Adult,
pubmed-meshheading:7547649-Female,
pubmed-meshheading:7547649-Fluvoxamine,
pubmed-meshheading:7547649-Humans,
pubmed-meshheading:7547649-Male,
pubmed-meshheading:7547649-Psychoses, Substance-Induced,
pubmed-meshheading:7547649-Schizophrenia,
pubmed-meshheading:7547649-Serotonin Uptake Inhibitors
|
pubmed:year |
1995
|
pubmed:articleTitle |
Psychotic symptoms in schizophrenics during chronic fluvoxamine treatment. A report of two cases.
|
pubmed:publicationType |
Letter,
Case Reports
|